13F 机构持仓

Parkman Healthcare Partners LLC

STAMFORD CT · SEC CIK 0001777015

2026Q22026Q1 更早 9 个季度 🔒
$9.70亿2026Q1 申报市值
90持仓数
34.7%前十大占比 · 第一大 5.2%
17 / 27新建仓 / 清仓
申报市值走势$9.77亿2026Q2
26Q126Q2

付费方案可看全部 11 个季度的走势 🔒

前十大持仓 占组合比例

SYK 5.2%
DXCM 4.5%
KALVISTA PHARM 3.8%
PODD 3.4%
LLY 3.3%
PTCT 3.0%
XENE 3.0%
BSX 2.9%
CVS 2.9%
RCUS 2.7%

2026Q1 买入最多 按季末市值估算

LLY 重新持有+$2,264.11万
QGEN 新建仓+$2,002.00万
XENE 加仓+$1,993.68万
PTCT 加仓+$1,847.58万
NVST 新建仓+$1,805.57万

2026Q1 卖出最多 按季末市值估算

MASIMO CORP 清仓-$2,601.20万
TERNS PHARMACEUT 清仓-$2,508.34万
QIAGEN NV 清仓-$2,223.10万
AMICUS THERAPEUT 清仓-$2,117.89万
MCK 减仓-$2,049.09万

2026Q1 持仓明细 点表头排序 · 每页 100 行

导出 CSV 🔒
代码名称市值 ▲占比股数变动股数变动估算买卖额操作
EYPT EYEPOINT INC $1,746.34万1.80%1,354,800 266,76724.5% $343.86万 加仓
NVST ENVISTA HOLDINGS CORPORATION $1,805.57万1.86%711,693 711,693— $1,805.57万 新建仓
QGEN QIAGEN NV $2,002.00万2.06%500,000 500,000— $2,002.00万 新建仓
SNDX SYNDAX PHARMACEUTICALS INC $2,105.93万2.17%901,511 327,48857.1% $765.01万 加仓
ANIP ANI PHARMACEUTICALS INC $2,157.62万2.23%280,575 135,57593.5% $1,042.57万 加仓
MBX MBX BIOSCIENCES INC $2,388.11万2.46%800,037 -85,602-9.7% -$255.52万 减仓
ZBH ZIMMER BIOMET HOLDINGS INC $2,437.33万2.51%269,557 118,50878.5% $1,071.55万 加仓
LIVN LIVANOVA PLC $2,567.60万2.65%403,965 -6,947-1.7% -$44.16万 减仓
RCUS ARCUS BIOSCIENCES INC $2,607.71万2.69%1,207,274 238,67224.6% $515.53万 加仓
CVS CVS HEALTH CORP $2,781.63万2.87%387,306 -62,906-14.0% -$451.79万 减仓
BSX BOSTON SCIENTIFIC CORP $2,816.02万2.90%448,768 -51,761-10.3% -$324.80万 减仓
XENE XENON PHARMACEUTICALS INC $2,890.26万2.98%497,035 342,851222.4% $1,993.68万 加仓
PTCT PTC THERAPEUTICS INC $2,938.88万3.03%431,364 271,185169.3% $1,847.58万 加仓
LLY ELI LILLY & CO $3,183.88万3.28%34,616 24,616246.2% $2,264.11万 重新持有
PODD INSULET CORP $3,285.28万3.39%156,561 15,70111.1% $329.47万 加仓
— KALVISTA PHARMACEUTICALS INC $3,694.87万3.81%1,835,506 66,9983.8% $134.87万 加仓
DXCM DEXCOM INC $4,332.08万4.47%689,822 102,34717.4% $642.74万 加仓
SYK STRYKER CORPORATION $5,085.62万5.24%154,771 49,29946.7% $1,619.92万 加仓